Inhibition of human cytochromes P450 by components of Ginkgo biloba (Q34337497)

1 August 2017

Inhibition of human cytochromes P450 by components of Ginkgo biloba (English)

1 reference

4-[5-(4-hydroxyphenyl)penta-1,4-dien-1-yl]phenol

1 August 2017

1 reference

1 reference

1 reference

3-Nonadec-8-enylbenzene-1,2-diol

1 reference

Erdal Bedir

3

0 references

Jerold S. Harmatz

series ordinal

5

object named as

Jerold S Harmatz

1 reference

1 August 2017

7

David J Greenblatt

1 reference

1 August 2017

1

Lisa L von Moltke

1 reference

1 August 2017

2

James L Weemhoff

1 reference

1 August 2017

4

Ikhlas A Khan

1 reference

1 August 2017

Peter Goldman

6

1 reference

1 August 2017

1 August 2004

1 reference

PubMed ID

15285849

full work available at URL

1 August 2017

https://academic.oup.com/jpp/article-pdf/56/8/1039/36735101/0022357044021.pdf

1 reference

19 March 2024

https://api.unpaywall.org/v2/10.1211/0022357044021?email=unpaywall_01@example.com

published in

Journal of Pharmacy and Pharmacology

1 reference

1 August 2017

56

1 reference

1 August 2017

8

1 reference

1 August 2017

1039-1044

1 reference

https://api.unpaywall.org/v2/10.1211/0022357044021?email=unpaywall_01@example.com

1 August 2017

1 reference

19 March 2024

access restriction status

open access

1 reference

based on heuristic

inferred from online access status

cites work

Biologically active secondary metabolites from Ginkgo biloba

1 reference

https://api.crossref.org/works/10.1211%2F0022357044021

Use of in vitro and in vivo data to estimate the likelihood of metabolic pharmacokinetic interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357044021

The Conduct of In Vitro and In Vivo Drug-Drug Interaction Studies: A PhRMA Perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357044021

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357044021

Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357044021

The risk-benefit profile of commonly used herbal therapies: Ginkgo, St. John's Wort, Ginseng, Echinacea, Saw Palmetto, and Kava

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357044021

21 January 2018

Herb-drug interactions

1 reference

https://api.crossref.org/works/10.1211%2F0022357044021

Relative contributions of CYP2C9 and 2C19 to phenytoin 4-hydroxylation in vitro: inhibition by sulfaphenazole, omeprazole, and ticlopidine

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357044021

Herbal medicines today and the roots of modern pharmacology

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357044021

Cytochrome P450 phenotypic ratios for predicting herb-drug interactions in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357044021

Interactions between herbal medicines and prescribed drugs: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357044021

Human P450 metabolism of warfarin

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357044021

Pharmaceutical quality of different Ginkgo biloba brands

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357044021

The CNS effects of Ginkgo biloba extracts and ginkgolide B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357044021

Multiple-Dose Administration of Ginkgo biloba Did Not Affect Cytochrome P-450 2D6 or 3A4 Activity in Normal Volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357044021

Hydroxylation of warfarin by human cDNA-expressed cytochrome P-450: a role for P-4502C9 in the etiology of (S)-warfarin-drug interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357044021

Benefits, adverse effects and drug interactions of herbal therapies with cardiovascular effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357044021

Chemical analysis of Ginkgo biloba leaves and extracts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357044021

Relative quantities of catalytically active CYP 2C9 and 2C19 in human liver microsomes: application of the relative activity factor approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357044021

Human drug metabolism and the cytochromes P450: application and relevance of in vitro models

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357044021

Drug Metabolism and Drug Interactions: Application and Clinical Value of In Vitro Models

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357044021

In vitro approaches to predicting drug interactions in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357044021

Effect of zolpidem on human cytochrome P450 activity, and on transport mediated by P-glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357044021

Interactions of herbs with cytochrome P450.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357044021

Effects of herbal components on cDNA-expressed cytochrome P450 enzyme catalytic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357044021

Interactions of warfarin with garlic, ginger, ginkgo, or ginseng: nature of the evidence

21 January 2018

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.1211/0022357044021

Human cytochromes P450 mediating phenacetin O-deethylation in vitro: validation of the high affinity component as an index of CYP1A2 activity

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.1211/0022357044021

Association of Ginkgo biloba with intracerebral hemorrhage

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.1211/0022357044021

Phenacetin O-deethylation by human liver microsomes in vitro: inhibition by chemical probes, SSRI antidepressants, nefazodone and venlafaxine

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.1211/0022357044021

Dietary intake and bioavailability of polyphenols

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.1211/0022357044021

Extraction of Flavonoid Glycosides from Ginkgo biloba Leaves and Their Adsorption Separations Using Hydrophobic and Anion-Exchange Membranes

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.1211/0022357044021

Protease inhibitors as inhibitors of human cytochromes P450: high risk associated with ritonavir

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.1211/0022357044021

Alprazolam metabolism in vitro: studies of human, monkey, mouse, and rat liver microsomes

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.1211/0022357044021

Multiple human cytochromes contribute to biotransformation of dextromethorphan in-vitro: role of CYP2C9, CYP2C19, CYP2D6, and CYP3A

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.1211/0022357044021

Identifiers

DOI

10.1211/0022357044021

1 reference

1 August 2017

1 reference

PubMed ID

15285849